Galleria mellonella immunological challenge with Leishmania promastigotes triggers changes on the profile expression of low molecular weight proteins
DOI:
https://doi.org/10.17533/udea.acbi.v39n107a02Keywords:
Hemolymph, 2D Electrophoresis, G. mellonella, Leishmania, AMPs, Protein profilesAbstract
The Leishmania parasite is responsible for several diseases that affect humans and animals in more than 95 countries including Colombia. Despite the known toxicity shown by current drugs such as Glucantime or Amphotericin B, they are still used as treatments against the parasite. Natural antimicrobial peptides (AMPs) are considered promising agents for use against a broad spectrum of infectious diseases, they are considered promising and non-toxic therapeutic agents. AMPs are part of the immune response of organisms such as insects, from where they have been isolated and shown to have antibacterial and antifungal activity. Galleria mellonella moths express a broad repertoire of peptides in response to challenges with different organisms. This suggests an alternative for obtaining peptides with anti-parasitic activity. This study was based on the immunological challenge induced in Galleria mellonella larvae with Leishmania (viannia) panamensis promastigotes, with the goal of isolating a peptide fraction with antiparasitic activity. Non-challenged hemolymph and hemolymph obtained from the immunization with PBS and parasites were compared. Free hemocyte hemolymph from each treatment was analyzed by two-dimensional electrophoresis (2D gel). Furthermore, hemolymphs were fractionated by RP-HPLC. 2D gel analysis identified 4 spots in challenged hemolymph and 3 spots in PBS hemolymph. These spots were not present in the control hemolymph. On the other hand, fractions from RP-HPLC of challenged hemolymph showed more antileishmania activity in comparison to the same fractions from the hemolymph control. This study may provide the basis for new antileishmanial peptides.
Downloads
References
Andrejko M, Mizerska-Dudka M, Jakubowicz T. 2009. Antibacterial activity in vivo and in vitro in the hemolymph of Galleria mellonella infected with Pseudomonas aeruginosa. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 152 (2): 118–23. DOI: 10.1016/j.cbpb.2008.10.008
Bergin D, Murphy L, Keenan J, Clynes M, Kavanagh K. 2006. Pre-exposure to yeast protects larvae of Galleria mellonella from a subsequent lethal infection by Candida albicans and is mediated by the increased expression of antimicrobial peptides. Microbes and Infection, 8 (8): 2105–12. DOI: 10.1016/j.micinf.2006.03.005
Blum J, Desjeux P, Schwartz E, Beck B, Hatz C. 2004. Treatment of cutaneous Leishmaniosis among travellers. The Journal of Antimicrobial Chemotherapy, 53 (2): 158–66. DOI: 10.1093/jac/dkh058
Boulanger N, Lowenberger C, Volf P, Ursic R, Sigutova L, Sabatier L, Svobodova M, Beverley SM, Spath G, Brun R, Pesson B, Bulet P. 2004. Characterization of a defensin from the sand fly Phlebotomus duboscqi induced by challenge with bacteria or the protozoan parasite Leishmania Major. Infection and Immunity, 72 (12): 7140–46. DOI: 10.1128/IAI.72.12.7140-7146.2004
Brey PT, Lee W J, Yamakawa M, Koizumi Y, Perrot S, François M, Ashida M. 1993. Role of the integument in insect immunity: epicuticular abrasion and induction of cecropin synthesis in cuticular epithelial cells. Proceedings of the National Academy of Sciences of the United States of America, 90 (13): 6275–79.
Brogden KA, Ackermann M, McCray PB, Tack BF. 2003. Antimicrobial peptides in animals and their role in host defences. International Journal of Antimicrobial Agents, 22 (5): 465–78.
Brown SE, Howard A, Kasprzak AB, Gordon K H, East PD. 2008. The discovery and analysis of a diverged Family of Novel Antifungal Moricin-like Peptides in the Wax Moth Galleria Mellonella. Insect biochemistry and Molecular Biology, 38 (2): 201–12. DOI: 10.1016/j.ibmb.2007.10.009
Brown SE, Howard A, Kasprzak, AB, Gordon, KH, East PD. 2009. A Peptidomics Study Reveals the Impressive Antimicrobial Peptide Arsenal of the Wax Moth Galleria Mellonella. Insect biochemistry and molecular biology 39 (11): 792–800. DOI: 10.1016/j.ibmb.2009.09.004
Bulet P, Charlet M, Hetru C. 2003. Antimicrobial Peptides in Insect Immunity. En: Ezekowitz RAB, Hoffmann JA, editores. Innate Inmunity. Totowa (U.S.A): Humana Press. p. 410 (89–107).
Chicharro C, Granata C, Lozano R, Andreu D, Rivas L. 2001. N-Terminal Fatty Acid Substitution increases the leishmanicidal activity of CA(1-7) M(2-9), a Cecropin- Melittin Hybrid Peptide. Antimicrobial Agents and Chemotherapy, 45 (9): 2441–49.
Cook SM, McArthur JD. 2013. Developing Galleria mellonella as a model host for human pathogens. Virulence, 4 (5): 350–53. DOI: 10.4161/viru.25240
Cytryńska M, Mak P, Zdybicka-Barabas A, Suder P, Jakubowicz T. 2007. Purification and characterization of eight peptides from Galleria mellonella immune hemolymph. Peptides, 28 (3): 533–46. DOI: 10.1016/j.peptides.2006.11.010
Díaz-Achirica P, Ubach J, Guinea A, Andreu D, Rivas L. 1998. The Plasma Membrane of Leishmania Donovani Promastigotes Is the Main Target for CA(1-8) M(1-18), a Synthetic Cecropin A-Melittin Hybrid Peptide. The Biochemical Journal, 330 (Pt 1): 453–60.
Frézard F, Demicheli C, Ribeiro RR. 2009. Pentavalent antimonials: new perspectives for old drugs. Molecules (Basel, Switzerland), 14 (7): 2317–36. DOI: 10.3390/molecules14072317
Hancock REW, Sahl HG. 2006. Antimicrobial and host-defense peptides as new anti- infective therapeutic strategies. Nature Biotechnology, 24 (12): 1551–57. DOI: 10.1038/nbt1267
Hoffmann JA, Hetru C. 1992. Insect defensins: Inducible antibacterial peptides. Immunology Today, 13 (10): 411–15. DOI: 10.1016/0167-5699(92)90092- L
Lewis DJ. 1971. Phlebotomid sandflies. Bulletin of the World Health Organization, 44 (4): 535–51.
Mak P, Zdybicka-Barabas A, Cytryńska M. 2010. A different repertoire of Galleria mellonella antimicrobial peptides in larvae challenged with bacteria and fungi. Developmental and Comparative Immunology, 34 (10): 1129–36. DOI:10.1016/j.dci.2010.06.005
Olliaro PL, Bryceson AD. 1993. Practical progress and new drugs for changing patterns of Leishmaniosis. Parasitology Today (Personal ed.), 9 (9): 323–28.
Rogers ME, Ilg T, Nikolaev AV, Ferguson MAJ, Bates PA. 2004. Transmission of cutaneous Leishmaniosis by sand flies is enhanced by regurgitation of fPPG. Nature, 430 (6998): 463–67. DOI: 10.1038/nature0267
Schoofs L, Holman GM, Hayes TK, Nachman RJ, De Loof A. 1990. Locustatachykinin I and II, two novel insect neuropeptides with homology to peptides of the vertebrate tachykinin family. FEBS letters 261 (2): 397–401. DOI: 10.1016/0014-5793(90)80601-E
Sundar S, Chakravarty J. 2010. Antimony toxicity. International Journal of Environmental Research and Public Health, 7 (12): 4267–77. DOI: 10.3390/ijerph7124267
de Vries HJC, Reedijk SH, Schallig HDFH. 2015. Cutaneous Leishmaniosis: recent developments in diagnosis and management. American Journal of Clinical Dermatology, 16 (2): 99–109. DOI: 10.1007/s40257-015- 0114-z
WHO. 2016. Organización mundial de la salud, Leishmaniosis [internet]. Fecha de acceso: 16 de agosto 2016. Disponible en: <http://www.who.int/es/>
Wojda I, Patryk-Kowalski I, Jakubowicz T. 2009. Humoral immune response of Galleria mellonella larvae after infection by Beauveria bassiana under optimal and heat- shock conditions. Journal of Insect Physiology, 55 (6): 525–31. DOI: 10.1016/j.jinsphys.2009.01.014
Wortmann G, Zapor M, Ressner R, Fraser S, Hartzell J, Pierson J, Weintrob A, Magill, A. 2010. Lipsosomal amphotericin B for treatment of cutaneous Leishmaniosis. The American Journal of Tropical Medicine and Hygiene, 83 (5): 1028–33. DOI: 10.4269/ajtmh.2010.10-0171
Wyatt GR. 1961. The biochemistry of insect hemolymph. Annual Review of Entomology, 6 (1): 75–102.
Yeaman MR, Yount NY. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacological Reviews, 55 (1): 27–55. DOI: 10.1124/pr.55.1.2
Zhao J, Zhao C, Liang G, Zhang M, Zheng J. 2013. Engineering antimicrobial peptides with improved antimicrobial and hemolytic activities. Journal of Chemical Information and Modeling, 53 (12): 3280–96. DOI: 10.1021/ci400477e
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Actualidades Biológicas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors exclusively authorize the Actualidades Biológicas journal to edit and publish the submitted manuscript if its publication is recommended and accepted, without this representing any cost to the Journal or the University of Antioquia.
All the ideas and opinions contained in the articles are sole responsibility of the authors. The total content of the issues or supplements of the journal is protected under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, so they cannot be used for commercial purposes, but for educational purposes. However, please mention the Actualidades Biológicas journal as a source and send a copy of the publication in which the content was reproduced.
